Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-15
2006-08-15
Stockton, Laura L. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S233800, C514S234500, C514S253110, C514S249000, C514S252100, C514S317000, C514S321000, C514S394000, C544S160000, C544S383000, C544S360000, C544S367000, C544S368000, C544S370000, C549S065000, C549S438000, C549S366000, C549S467000, C546S270100, C546S234000, C546S198000, C546S293000, C564S078000, C564S082000
Reexamination Certificate
active
07091219
ABSTRACT:
Bis-sulfonamido hydroxyethylamino compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. The present invention relates to retroviral protease inhibiting compounds of the formula:or a pharmaceutically acceptable salt, prodrug or ester thereof, wherein the variables are as defined herein.
REFERENCES:
patent: 4477441 (1984-10-01), Boger et al.
patent: 4514391 (1985-04-01), Gordon et al.
patent: 4599198 (1986-07-01), Hoover
patent: 4616088 (1986-10-01), Ryono et al.
patent: 4668769 (1987-05-01), Hoover
patent: 4668770 (1987-05-01), Boger et al.
patent: 4757050 (1988-07-01), Natarajan et al.
patent: 4880938 (1989-11-01), Freidinger
patent: H725 (1990-01-01), Gordon
patent: 4963530 (1990-10-01), Hemmi et al.
patent: 4977277 (1990-12-01), Rosenberg et al.
patent: 5157041 (1992-10-01), Handa et al.
patent: 5458926 (1995-10-01), VerMehren
patent: 5508294 (1996-04-01), Vazquez et al.
patent: 5521219 (1996-05-01), Vazquez et al.
patent: 5639769 (1997-06-01), Vazquez et al.
patent: 5760064 (1998-06-01), Vazquez et al.
patent: 6143747 (2000-11-01), Freskos et al.
patent: 6384036 (2002-05-01), Freskos et al.
patent: 104041 (1984-03-01), None
patent: 114993 (1984-06-01), None
patent: 172347 (1986-02-01), None
patent: 223437 (1987-05-01), None
patent: 0 264 795 (1988-04-01), None
patent: 337714 (1989-10-01), None
patent: 0 342 541 (1989-11-01), None
patent: 0 346 847 (1989-12-01), None
patent: 356223 (1990-02-01), None
patent: 389898 (1990-10-01), None
patent: 389898 (1990-10-01), None
patent: 393445 (1990-10-01), None
patent: 393457 (1990-10-01), None
patent: 402646 (1990-12-01), None
patent: 468641 (1992-01-01), None
patent: 2184730 (1987-07-01), None
patent: 2200115 (1988-07-01), None
patent: 2209752 (1989-05-01), None
patent: WO84/03044 (1984-08-01), None
patent: WO 92/00750 (1992-01-01), None
patent: 93/10134 (1993-05-01), None
patent: 93/10136 (1993-05-01), None
patent: 93/23368 (1993-11-01), None
patent: 93/23379 (1993-11-01), None
patent: 94/04491 (1994-03-01), None
patent: 94/04492 (1994-03-01), None
patent: 94/04493 (1994-03-01), None
patent: 94/05639 (1994-03-01), None
Thornber, Chemical Society Reviews, vol. 8, No. 1, 1979, pp. 563-580 (1979).
Rich et al., Peptide Inhibitors of Proteases, 511-520, 1983.
Rosenberg et al.,J. Med. Chem. 30, 1224-1228 (1987).
Roberts et al., “Rational Design of Peptide-Based Proteinase Inhibitors,”Science, 248, 358 (1990).
Erickson et al., “Design activity and 2.8A Crystal Structure of a C2Symmetric Inhibitor Complexed to HIV-1 Protease,”Science, 249, 527 (1990).
Pearl et al., “Sequence Specificity of Retroviral Proteases”Nature, 328 (1987).
Martin,Drugs of the Future, 16(3), 210-212 (1991).
Meek et al.,Letter To Nature, 343, 90-92 (1990).
McQuade et al.,Science, 247, 454-456, 1990.
Freskos John N.
Getman Daniel P.
Sikorski James A.
Talley John J.
Banner & Witcoff , Ltd.
G. D. Searle & Co.
Stockton Laura L.
LandOfFree
Bis-sulfonamide hydroxyethyl-amino retroviral protease... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bis-sulfonamide hydroxyethyl-amino retroviral protease..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bis-sulfonamide hydroxyethyl-amino retroviral protease... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3714982